Copyright
©The Author(s) 2022.
World J Gastroenterol. Oct 28, 2022; 28(40): 5881-5892
Published online Oct 28, 2022. doi: 10.3748/wjg.v28.i40.5881
Published online Oct 28, 2022. doi: 10.3748/wjg.v28.i40.5881
Table 4 Acute-on-chronic liver failure posttransplant outcomes (n = 95)
| ACLF-1, n = 40 (42.1%) | ACLF-2, n = 33 (34.7%) | ACLF-3, n = 22 (23.2%) | P value | |
| ICU stay (d) | 3.0 (2.0-4.0) | 3.0 (2.0-6.0) | 3.0 (2.0-6.0) | 0.68 |
| Hospital stay (d) | 8.0 (5.0-11.8) | 8.0 (6.0-15.5) | 6.0 (5.8-14.3) | 0.54 |
| Any type of complication, n (%) | 35 (87.5) | 31 (93.9) | 19 (86.4) | 0.58 |
| Infectious complications, n (%) | 20 (50.0) | 15 (45.5) | 12 (54.5) | 0.80 |
| Complications (Clavien-Dindo), n (%) | ||||
| I | 7 (17.5) | 6 (18.2) | 6 (27.3) | 0.62 |
| II | 17 (42.5) | 11 (33.3) | 4 (18.2) | 0.15 |
| III | 5 (12.5) | 7 (21.2) | 5 (22.7) | 0.50 |
| IV | 4 (10.0) | 6 (18.2) | 2 (9.1) | 0.49 |
| V | 2 (5.0) | 1 (3.0) | 2 (9.1) | 0.61 |
- Citation: Cervantes-Alvarez E, Vilatoba M, Limon-de la Rosa N, Mendez-Guerrero O, Kershenobich D, Torre A, Navarro-Alvarez N. Liver transplantation is beneficial regardless of cirrhosis stage or acute-on-chronic liver failure grade: A single-center experience. World J Gastroenterol 2022; 28(40): 5881-5892
- URL: https://www.wjgnet.com/1007-9327/full/v28/i40/5881.htm
- DOI: https://dx.doi.org/10.3748/wjg.v28.i40.5881